HyperSpectral appoints Rob Donofrio as chief life science officer
HyperSpectral appointed Rob Donofrio to lead life-science product development, validation and market strategy.
Evidence notes
- Donofrio is responsible for product development and validation across biotechnology, industrial microbiology and public-health applications.
- His remit includes regulatory positioning and integration of spectral intelligence into laboratory and industrial workflows.
- The appointment followed HyperSpectral's combined $15.5 million Series A-1 and Series A-2 financing.